HEMANGIOBLASTOMA
Clinical trials for HEMANGIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HEMANGIOBLASTOMA trials appear
Sign up with your email to follow new studies for HEMANGIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: HEMANGIOBLASTOMA
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
New scan could spot hidden brain tumors missed by standard MRI
Diagnosis Recruiting nowThis study is testing whether a special type of PET/MRI scan, called 68Ga-DOTATATE, can better detect brain tumors or tell if a tumor has come back after treatment. The study includes 200 adults with certain brain tumors, like meningioma. The goal is to see if this scan gives doc…
Matched conditions: HEMANGIOBLASTOMA
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Diagnosis
Last updated May 22, 2026 13:53 UTC
-
New brain tumor labels could change how doctors treat you
Knowledge-focused Recruiting nowThis study watches 1650 people with different types of brain tumors to see if the new 2021 classification system helps doctors choose better treatments. Researchers will track how long patients live and how well their tumors respond to therapy. The goal is to create clearer treat…
Matched conditions: HEMANGIOBLASTOMA
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Knowledge-focused
Last updated May 26, 2026 06:42 UTC